{
    "Trade/Device Name(s)": [
        "MASTALEX\u2122- MRSA",
        "MASTALEX\u00ae - MRSA"
    ],
    "Submitter Information": "Mast Group Ltd.",
    "510(k) Number": "K062864",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011400"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYI"
    ],
    "Summary Letter Date": "October 18, 2006",
    "Summary Letter Received Date": "September 25, 2006",
    "Submission Date": "September 22, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Penicillin binding protein 2'",
        "Methicillin Resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Pre-isolated Staphylococcus aureus organisms"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Rapid slide latex agglutination"
    ],
    "Methodologies": [
        "Latex agglutination assay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Accessory",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for MASTALEX\u2122- MRSA rapid latex kit to confirm MRSA via PBP2' detection in Staphylococcus aureus isolates",
    "Indications for Use Summary": "A rapid slide latex test for detection of penicillin binding protein 2' and confirmation of Methicillin Resistant Staphylococcus aureus",
    "fda_folder": "Microbiology"
}